Duration of Sumatriptan Therapy
Sumatriptan is given as a single dose at the onset of migraine, with a possible second dose at least 2 hours later if needed, but the maximum duration is 24 hours with a total daily limit of 200 mg (oral) or two 6 mg doses (subcutaneous). 1
Dosing Timeline and Limits
Initial Dose
- Administer sumatriptan immediately at migraine onset for optimal efficacy 2
- Oral: 25 mg, 50 mg, or 100 mg as a single dose 1
- Subcutaneous: 6 mg as a single dose 1
Second Dose Criteria
If the migraine persists or returns after initial improvement:
- Wait at least 2 hours after the first dose before giving a second dose 1
- The second dose should only be used for headache recurrence, not for inadequate initial response 3
- Evidence shows a second dose for non-responders is not significantly more effective than placebo 3
Maximum Daily Limits
- Oral sumatriptan: 200 mg total in 24 hours 1
- Subcutaneous: Two 6 mg doses maximum in 24 hours 1
- After subcutaneous injection, additional oral doses (up to 100 mg/day) may be given with at least 2-hour intervals 1
Critical Safety Considerations
Medication Overuse Headache Risk
Do not use sumatriptan on ≥10 days per month to avoid medication overuse headache 2. This threshold is lower than NSAIDs (≥15 days/month) and represents a critical safety boundary.
Treatment Frequency Limits
- The safety of treating more than 4 headaches in a 30-day period has not been established 1
- If episodic migraines occur frequently despite acute treatment, add preventive medications rather than increasing acute treatment frequency 2
Special Populations
Hepatic Impairment
Maximum single dose: 50 mg in patients with mild to moderate hepatic impairment 1
Clinical Pitfalls to Avoid
- Do not give a second dose for inadequate initial response - reserve it only for recurrence after initial relief 3
- Do not exceed daily maximums - this increases adverse events without additional benefit 1
- Do not use during migraine aura - wait until headache phase begins 4
- Do not combine with ergotamines or other vasoconstrictors 4